Boehringer Ingelheim, IP Group, the UK Respiratory Gene Therapy Consortium (GTC)1 and OXB,1 today announce the start of LENTICLAIRTM 1, a Phase I/II trial of BI 3720931, a novel, first-in-class, gene ...

The most common form of lung cancer is primarily found in non-smokers, a new study reveals. Doctors react to the surprising driver of the disease and other risk factors.

Human health is strongly intertwined with the health of the microbiome. A large number of studies have shown that the human ...

In localized non-small cell lung cancer (NSCLC), a tumor's ability to use carbon from glucose to feed the tricarboxylic acid ...

Infusion reactions that can sometimes be severe or life-threatening. Signs and symptoms of infusion reactions may include: ...

Ridgefield, Conn., U.S., and Ingelheim, GermanyZongertinib would be the first orally administered, targeted therapy for previously treated ...

LAKELAND, Fla. - Lakeland Regional Health is using new cutting-edge technology to help them cure lung cancer. Lung cancer can be a deadly disease, and the further it spreads, the more harmful it is.

While the number of smokers in the world as a proportion of the population is dropping, lung cancer continues to cause almost ...

Lung cancer is one of the most common, most dangerous, and most frequently talked about forms of cancer in the world. Of all ...

New Screening Device Shows Promise for Early Lung Cancer Detection Feb. 6, 2025 — Scientists have created a new low-cost, fast response sensor to detect lung cancer biomarkers, paving the way ...

Despite new paradigm-shifting treatments, lung cancer remains a deadly disease – and improving outcomes requires more than just drug research. The new Lung Ambition Alliance – launched in July ...

The discovery is of great interest for cancer medicine because a change of ... Lung Cancer Cells Can Go 'Off Grid' Feb. 12, 2025 — Researchers have found that some particularly aggressive lung ...